Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
132
NCT00809796
A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 31, 2008
Completion: Jun 30, 2011
NCT00810953
A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy
Start: Jan 31, 2009
NCT01378143
Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy
Phase: Phase 2
Start: Mar 31, 2011
Completion: Jul 31, 2014
NCT01844791
An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients
Start: Sep 30, 2012
Completion: Jan 31, 2014
NCT02210182
A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
Phase: Phase 1
Start: Aug 31, 2014
Completion: Dec 31, 2015